Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    21830957 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?
Condition: Acute Kidney Injury
Intervention:
2 Recruiting Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
Conditions: Coronary Artery Bypass Grafting;   Postoperative Atrial Fibrilation;   Stroke;   Systemic Embolism;   Deep Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
3 Recruiting Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Dabigatran etexilate;   Drug: Rivaroxaban;   Drug: Apixaban
4 Recruiting Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
Condition: Atrial Fibrillation and Flutter
Intervention: Other: New oral anticoagulant pharmacodynamic analysis (blood level assesment)
5 Not yet recruiting Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban
Conditions: Atrial Fibrillation;   Stroke
Interventions: Device: WATCHMAN Left Atrial Appendage Occlusion Device;   Drug: Rivaroxaban
6 Recruiting Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: NOAC;   Device: Left atrial appendage closure
7 Completed
Has Results
Genetic Response to Warfarin in Healthy Subjects
Condition: Healthy
Intervention: Drug: Warfarin
8 Completed
Has Results
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke;   Embolism
Interventions: Drug: Rivaroxaban;   Drug: Warfarin;   Drug: Matching placebo for Rivaroxaban arm (Warfarin placebo);   Drug: Matching placebo for Warfarin arm (Rivaroxaban placebo)

Indicates status has not been verified in more than two years